跳至主要内容
临床试验/NCT07376603
NCT07376603招募中不适用

Intensity-Modulated Radiotherapy Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features

Qiaojuan Guo1 个研究点 分布在 1 个国家目标入组 169 人开始时间: 2026年1月12日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
169
试验地点
1
主要终点
Relapse-Free Survival

研究概览

简要总结

This observational study aims to evaluate the efficacy and safety of intensity-modulated radiotherapy (IMRT) alone in patients with stage IB nasopharyngeal carcinoma (NPC) without high-risk features. The primary objective is to determine the therapeutic effectiveness of this approach

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 1. Histopathologically confirmed, newly diagnosed nasopharyngeal carcinoma
  • Age 18-70 years
  • Stage IB disease (T1-2N1M0) per the 9th edition AJCC/UICC staging system
  • Upper-neck nodal metastasis only: inferior border of every positive node at or above the inferior border of the hyoid bone
  • ECOG performance status 0-2
  • Adequate bone-marrow function

排除标准

  • Age > 70 years or < 18 years
  • Matted lymph nodes: two or more contiguous nodes with loss of intervening fat planes and/or extracapsular extension forming a confluent mass
  • Largest metastatic lymph-node ≥ 3 cm in the longest dimension
  • Lower-neck nodal metastasis: inferior border of any positive node below the inferior border of the hyoid bone
  • Prior malignancy except adequately treated basal-cell or squamous-cell carcinoma of the skin or carcinoma in situ of the cervix
  • Pregnancy or lactation (serum pregnancy test required for women of child-bearing potential; effective contraception mandatory during treatment)
  • Previous radiotherapy to the head-and-neck region
  • Prior chemotherapy or surgery for the primary tumour or metastatic nodes (diagnostic procedures excluded)
  • Any severe comorbidity that would confer unacceptable risk or compromise protocol adherence, including but not limited to unstable cardiac disease, renal failure, chronic hepatitis, or uncontrolled psychiatric disorder
  • History of severe hypersensitivity reactions

研究组 & 干预措施

IMRT along

IMRT Alone for 169 Patients with Stage IB Nasopharyngeal Carcinoma Without High-Risk Features

干预措施: IMRT along (Radiation)

结局指标

主要结局

Relapse-Free Survival

时间窗: 3-year

Time from diagnosis to the disease relapse (either locoregional recurrence or distant metastasis) or death from any cause.

次要结局

  • Locoregional Relapse-Free Survival(3-year)
  • Distant Metastasis-Free Survival(3-year)
  • Overall Survival(3-year)
  • Safety of Radiation(at inclusion, 3 months, 6 months,12 months, 24 months, 36 months, and 60 months)
  • Quality of life (EORTC QLQ C30)(at inclusion, 3 months, 6 months,12 months, 24 months, 36 months, and 60 months.)
  • Quality of life score QLQ-HN35(at inclusion, 3 months, 6 months,12 months, 24 months, 36 months, and 60 months.)

研究者

发起方
Qiaojuan Guo
申办方类型
Other Gov
责任方
Sponsor Investigator
主要研究者

Qiaojuan Guo

Professor

Fujian Cancer Hospital

研究点 (1)

Loading locations...

相似试验